85 related articles for article (PubMed ID: 22735680)
1. Transcriptomic study of dormant gastrointestinal cancer stem cells.
Nishikawa S; Dewi DL; Ishii H; Konno M; Haraguchi N; Kano Y; Fukusumi T; Ohta K; Noguchi Y; Ozaki M; Sakai D; Satoh T; Doki Y; Mori M
Int J Oncol; 2012 Sep; 41(3):979-84. PubMed ID: 22735680
[TBL] [Abstract][Full Text] [Related]
2. Genotoxic therapy stimulates error-prone DNA repair in dormant hepatocellular cancer stem cells.
Nishikawa S; Ishii H; Haraguchi N; Kano Y; Fukusumi T; Ohta K; Ozaki M; Sakai D; Satoh T; Nagano H; Doki Y; Mori M
Exp Ther Med; 2012 Jun; 3(6):959-962. PubMed ID: 22969999
[TBL] [Abstract][Full Text] [Related]
3. Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon.
Kim HM; Haraguchi N; Ishii H; Ohkuma M; Okano M; Mimori K; Eguchi H; Yamamoto H; Nagano H; Sekimoto M; Doki Y; Mori M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S539-48. PubMed ID: 21879266
[TBL] [Abstract][Full Text] [Related]
4. CD13: Waving the flag for a novel cancer stem cell target.
Christ B; Stock P; Dollinger MM
Hepatology; 2011 Apr; 53(4):1388-90. PubMed ID: 21480341
[TBL] [Abstract][Full Text] [Related]
5. Tumor dormancy and cancer stem cells: two sides of the same coin?
Kleffel S; Schatton T
Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
[TBL] [Abstract][Full Text] [Related]
6. CD13 is a therapeutic target in human liver cancer stem cells.
Haraguchi N; Ishii H; Mimori K; Tanaka F; Ohkuma M; Kim HM; Akita H; Takiuchi D; Hatano H; Nagano H; Barnard GF; Doki Y; Mori M
J Clin Invest; 2010 Sep; 120(9):3326-39. PubMed ID: 20697159
[TBL] [Abstract][Full Text] [Related]
7. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
[TBL] [Abstract][Full Text] [Related]
8. Radiation resistance: Cancer stem cells (CSCs) and their enigmatic pro-survival signaling.
Skvortsova I; Debbage P; Kumar V; Skvortsov S
Semin Cancer Biol; 2015 Dec; 35():39-44. PubMed ID: 26392376
[TBL] [Abstract][Full Text] [Related]
9. The epigenetic/noncoding origin of tumor dormancy.
Crea F; Nur Saidy NR; Collins CC; Wang Y
Trends Mol Med; 2015 Apr; 21(4):206-11. PubMed ID: 25771096
[TBL] [Abstract][Full Text] [Related]
10. Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells.
Nakayama M; Ogasawara S; Akiba J; Ueda K; Koura K; Todoroki K; Kinoshita H; Yano H
J Gastroenterol Hepatol; 2014 May; 29(5):1092-101. PubMed ID: 24325739
[TBL] [Abstract][Full Text] [Related]
11. Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines.
Yan X; Luo H; Zhou X; Zhu B; Wang Y; Bian X
Oncol Rep; 2013 Dec; 30(6):2733-40. PubMed ID: 24101104
[TBL] [Abstract][Full Text] [Related]
12. Novel therapeutic target for cancer stem cells in hepatocellular carcinoma.
Nagano H; Ishii H; Marubashi S; Haraguchi N; Eguchi H; Doki Y; Mori M
J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):600-5. PubMed ID: 22892595
[TBL] [Abstract][Full Text] [Related]
13. Digital gene expression profiling analysis of DNA repair pathways in colon cancer stem population of HT29 cells.
Wang W; Zhang G; Yang J; Gu H; Ding L; Yu H; Yu M; Cui Q; Ji X; Li M
Acta Biochim Biophys Sin (Shanghai); 2017 Jan; 49(1):90-100. PubMed ID: 27932392
[TBL] [Abstract][Full Text] [Related]
14. Tumor dormancy: long-term survival in a hostile environment.
Quesnel B
Adv Exp Med Biol; 2013; 734():181-200. PubMed ID: 23143980
[TBL] [Abstract][Full Text] [Related]
15. Significance of CD90+ cancer stem cells in human liver cancer.
Yang ZF; Ho DW; Ng MN; Lau CK; Yu WC; Ngai P; Chu PW; Lam CT; Poon RT; Fan ST
Cancer Cell; 2008 Feb; 13(2):153-66. PubMed ID: 18242515
[TBL] [Abstract][Full Text] [Related]
16. CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells.
Yamazaki H; Nishida H; Iwata S; Dang NH; Morimoto C
Biochem Biophys Res Commun; 2009 May; 383(2):172-7. PubMed ID: 19341705
[TBL] [Abstract][Full Text] [Related]
17. Identification of local and circulating cancer stem cells in human liver cancer.
Yang ZF; Ngai P; Ho DW; Yu WC; Ng MN; Lau CK; Li ML; Tam KH; Lam CT; Poon RT; Fan ST
Hepatology; 2008 Mar; 47(3):919-28. PubMed ID: 18275073
[TBL] [Abstract][Full Text] [Related]
18. Emerging role of microRNAs in cancer and cancer stem cells.
Hao J; Zhao S; Zhang Y; Zhao Z; Ye R; Wen J; Li J
J Cell Biochem; 2014 Apr; 115(4):605-10. PubMed ID: 24166873
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cells may be mostly maintained by fluctuating hypoxia.
Sun Q; Li X; Lu X; Di B
Med Hypotheses; 2011 Apr; 76(4):471-3. PubMed ID: 21159447
[TBL] [Abstract][Full Text] [Related]
20. RNA editing-dependent epitranscriptome diversity in cancer stem cells.
Jiang Q; Crews LA; Holm F; Jamieson CHM
Nat Rev Cancer; 2017 Jun; 17(6):381-392. PubMed ID: 28416802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
